A C-level biotech leader with over 20 years building and scaling life sciences businesses across Europe, the Middle East, and Asia. Track record includes co-founding multiple biotech companies spanning oncology, immunotherapy, vaccines, and systems biology, collectively raising over $500m and delivering multiple exits, including a recent acquisition by a major global pharma titan.

Most recently they have led the build out of a brand new biotech ecosystem, starting from scratch, to deliveing over $1bn in investment into the new region, with new labs and companies formed. Deep, hands-on experience across the full company-building lifecycle: formation, fundraising, PoC execution, clinical development, and M&A.

Distinctive value lies in a well-established network of strategic partnerships with Asian integrated drug development platforms, enabling discovery-to-PoC execution at roughly a third of the typical cost and timeline, a capability increasingly sought by capital-constrained biotechs seeking efficiencies across their route to the clinic. Open to full-time or part-time CEO and Board Member mandates with preclinical and early-clinical stage companies across Europe and the US, bringing both operating leadership and an active angel investing/venture-building network.

Download Candidate Profile